0000921895-21-000544.txt : 20210223 0000921895-21-000544.hdr.sgml : 20210223 20210223180157 ACCESSION NUMBER: 0000921895-21-000544 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210219 FILED AS OF DATE: 20210223 DATE AS OF CHANGE: 20210223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Erdtmann Rainer M CENTRAL INDEX KEY: 0001455767 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36866 FILM NUMBER: 21667178 MAIL ADDRESS: STREET 1: 1073 ARLINGTON BLVD. CITY: EL CERRITO STATE: CA ZIP: 94530 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics Inc. CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-514-7149 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Summit Therapeutics plc DATE OF NAME CHANGE: 20150219 FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 4 1 form412566erd_02232021.xml OWNERSHIP DOCUMENT X0306 4 2021-02-19 0 0001599298 Summit Therapeutics Inc. SMMT 0001455767 Erdtmann Rainer M C/O SUMMIT THERAPEUTICS INC., ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 1 0 0 0 Stock Option (right to buy) 7.33 2021-02-19 4 A 0 25000 A 2021-12-31 2031-02-19 Common Stock 25000 252273 D The option was granted on February 19, 2021. The shares underlying the option are scheduled to vest in full on December 31, 2021. Not applicable. /s/ Michael Paul Donaldson, Attorney-in-Fact 2021-02-23